Ph2 umbrella study with rolling arms of pembro in treatment with NSCLC (MK-3475-01E)
Phase II Clinical Trial
MK3475-U01 Master Study: A Phase 1/2 Umbrella Study with Rolling Arms of Investigational Agents Pembrolizumab and Chemotherapy Alone or in Combination in Participants with Non-small Cell Lung Cancer (NSCLC): MK3475- 01E Sub Study: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
Participating Locations